Stephen MacLennan

1.4k total citations
19 papers, 1.1k citations indexed

About

Stephen MacLennan is a scholar working on Physiology, Molecular Biology and Cancer Research. According to data from OpenAlex, Stephen MacLennan has authored 19 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Physiology, 6 papers in Molecular Biology and 5 papers in Cancer Research. Recurrent topics in Stephen MacLennan's work include Adenosine and Purinergic Signaling (13 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Nitric Oxide and Endothelin Effects (2 papers). Stephen MacLennan is often cited by papers focused on Adenosine and Purinergic Signaling (13 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Nitric Oxide and Endothelin Effects (2 papers). Stephen MacLennan collaborates with scholars based in Italy, United Kingdom and United States. Stephen MacLennan's co-authors include Pier Andrea Borea, Stefania Gessi, Katia Varani, Stefania Merighi, Edward Leung, Annalisa Benini, Prisco Mirandola, Pier Giovanni Baraldi, Edward Leung and Graeme R. Martin and has published in prestigious journals such as Journal of Biological Chemistry, American Journal of Respiratory and Critical Care Medicine and Clinical Cancer Research.

In The Last Decade

Stephen MacLennan

19 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen MacLennan Italy 15 720 462 138 126 125 19 1.1k
Faina Barer Israel 18 1.0k 1.4× 578 1.3× 202 1.5× 81 0.6× 93 0.7× 26 1.4k
Avivit Ochaion Israel 15 866 1.2× 490 1.1× 187 1.4× 92 0.7× 86 0.7× 19 1.2k
Elena Cattabriga Italy 13 649 0.9× 398 0.9× 87 0.6× 115 0.9× 133 1.1× 16 926
Hongyan Zhong United States 17 939 1.3× 382 0.8× 220 1.6× 216 1.7× 147 1.2× 25 1.4k
Ethan J. Stam United States 9 673 0.9× 520 1.1× 391 2.8× 106 0.8× 59 0.5× 10 1.4k
Elisa Orioli Italy 17 712 1.0× 408 0.9× 260 1.9× 101 0.8× 48 0.4× 21 1.2k
Carmen Corciulo United States 20 342 0.5× 352 0.8× 108 0.8× 88 0.7× 126 1.0× 42 1.0k
Wenjun Zhang China 18 251 0.3× 521 1.1× 91 0.7× 62 0.5× 193 1.5× 76 1.1k
Valentina Vultaggio-Poma Italy 13 374 0.5× 288 0.6× 97 0.7× 82 0.7× 37 0.3× 24 724
Anna Pegoraro Italy 13 605 0.8× 281 0.6× 210 1.5× 68 0.5× 34 0.3× 22 870

Countries citing papers authored by Stephen MacLennan

Since Specialization
Citations

This map shows the geographic impact of Stephen MacLennan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen MacLennan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen MacLennan more than expected).

Fields of papers citing papers by Stephen MacLennan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen MacLennan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen MacLennan. The network helps show where Stephen MacLennan may publish in the future.

Co-authorship network of co-authors of Stephen MacLennan

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen MacLennan. A scholar is included among the top collaborators of Stephen MacLennan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen MacLennan. Stephen MacLennan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Gessi, Stefania, Valeria Sacchetto, Stefania Merighi, et al.. (2010). Modulation of metalloproteinase-9 in U87MG glioblastoma cells by A3 adenosine receptors. Biochemical Pharmacology. 79(10). 1483–1495. 57 indexed citations
2.
Varani, Katia, Fabrizio Vincenzi, Stefania Gessi, et al.. (2009). A 2A adenosine receptor overexpression and functionality, as well as TNF‐α levels, correlate with motor symptoms in Parkinson's disease. The FASEB Journal. 24(2). 587–598. 99 indexed citations
3.
Varani, Katia, Gaetano Caramori, Fabrizio Vincenzi, et al.. (2009). Oxidative/nitrosative stress selectively altered A 2B adenosine receptors in chronic obstructive pulmonary disease. The FASEB Journal. 24(4). 1192–1204. 15 indexed citations
4.
Gessi, Stefania, Valeria Sacchetto, Stefania Merighi, et al.. (2009). Adenosine Modulates HIF-1α, VEGF, IL-8, and Foam Cell Formation in a Human Model of Hypoxic Foam Cells. Arteriosclerosis Thrombosis and Vascular Biology. 30(1). 90–97. 63 indexed citations
5.
Merighi, Stefania, Annalisa Benini, Prisco Mirandola, et al.. (2007). Caffeine Inhibits Adenosine-Induced Accumulation of Hypoxia-Inducible Factor-1α, Vascular Endothelial Growth Factor, and Interleukin-8 Expression in Hypoxic Human Colon Cancer Cells. Molecular Pharmacology. 72(2). 395–406. 127 indexed citations
6.
Gessi, Stefania, Katia Varani, Stefania Merighi, et al.. (2007). Adenosine and lymphocyte regulation. Purinergic Signalling. 3(1-2). 109–16. 70 indexed citations
7.
Merighi, Stefania, Annalisa Benini, Prisco Mirandola, et al.. (2007). Hypoxia Inhibits Paclitaxel-Induced Apoptosis through Adenosine-Mediated Phosphorylation of Bad in Glioblastoma Cells. Molecular Pharmacology. 72(1). 162–172. 65 indexed citations
8.
Merighi, Stefania, Annalisa Benini, Prisco Mirandola, et al.. (2006). Adenosine modulates vascular endothelial growth factor expression via hypoxia-inducible factor-1 in human glioblastoma cells. Biochemical Pharmacology. 72(1). 19–31. 100 indexed citations
9.
Merighi, Stefania, Annalisa Benini, Prisco Mirandola, et al.. (2006). Modulation of the Akt/Ras/Raf/MEK/ERK pathway by A3 adenosine receptor. Purinergic Signalling. 2(4). 627–632. 33 indexed citations
10.
Merighi, Stefania, Annalisa Benini, Prisco Mirandola, et al.. (2005). A3 Adenosine Receptor Activation Inhibits Cell Proliferation via Phosphatidylinositol 3-Kinase/Akt-dependent Inhibition of the Extracellular Signal-regulated Kinase 1/2 Phosphorylation in A375 Human Melanoma Cells. Journal of Biological Chemistry. 280(20). 19516–19526. 100 indexed citations
11.
Merighi, Stefania, Annalisa Benini, Prisco Mirandola, et al.. (2005). A3 Adenosine Receptors Modulate Hypoxia-inducible Factor-1a Expression in Human A375 Melanoma Cells. Neoplasia. 7(10). 894–903. 67 indexed citations
12.
Varani, Katia, Gaetano Caramori, Fabrizio Vincenzi, et al.. (2005). Alteration of Adenosine Receptors in Patients with Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 173(4). 398–406. 89 indexed citations
13.
Stewart, M. K., Arno G. Steinig, Jianping Song, et al.. (2004). [3H]OSIP339391, a selective, novel, and high affinity antagonist radioligand for adenosine A2B receptors. Biochemical Pharmacology. 68(2). 305–312. 45 indexed citations
14.
Gessi, Stefania, Elena Cattabriga, Roberta Gafà, et al.. (2004). Elevated Expression of A3 Adenosine Receptors in Human Colorectal Cancer Is Reflected in Peripheral Blood Cells. Clinical Cancer Research. 10(17). 5895–5901. 138 indexed citations
15.
Martin, Renée S., Paul Reynen, Thomas K. H. Chang, et al.. (2002). Pharmacological Comparison of a Recombinant CB1 Cannabinoid Receptor with Its Ga16 Fusion Product. SLAS DISCOVERY. 7(3). 281–289. 6 indexed citations
16.
MacLennan, Stephen, et al.. (1998). Cranial vascular effects of zolmitriptan, a centrally active 5-HT1B/1D receptor partial agonist for the acute treatment of migraine. European Journal of Pharmacology. 361(2-3). 191–197. 11 indexed citations
17.
MacLennan, Stephen, et al.. (1993). Amplifying interactions between spasmogens in vascular smooth muscle. Biochemical Society Transactions. 21(4). 1145–1150. 14 indexed citations
18.
MacLennan, Stephen & Graeme R. Martin. (1992). Effect of the thromboxane A2‐mimetic U46619 on 5‐HT1‐like and 5‐HT2 receptor‐mediated contraction of the rabbit isolated femoral artery. British Journal of Pharmacology. 107(2). 418–421. 34 indexed citations
19.
MacLennan, Stephen, J.C. McGrath, & Martin Whittle. (1988). Inhibition of the oxygen-induced contraction of the isolated human umbilical artery by indomethacin, flurbiprofen, aspirin and drugs modifying Ca2+ disposition. Prostaglandins. 36(5). 711–729. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Faina Barer Breakdown of academic impact, for papers by Avivit Ochaion Breakdown of academic impact, for papers by Elena Cattabriga Breakdown of academic impact, for papers by Hongyan Zhong Breakdown of academic impact, for papers by Ethan J. Stam Breakdown of academic impact, for papers by Elisa Orioli Breakdown of academic impact, for papers by Carmen Corciulo Breakdown of academic impact, for papers by Wenjun Zhang Breakdown of academic impact, for papers by Valentina Vultaggio-Poma Breakdown of academic impact, for papers by Anna Pegoraro
Rankless by CCL
2026